EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS073-13765 
Organism
Homo sapiens 
Tissue/cell
GM19238 
Coordinate
chr8:28185800-28186650 
Target genes
Number: 6             
NameEnsembl ID
TF binding sites/motifs
Number: 1             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Nr2f6(var.2)MA0728.1chr8:28185813-28185828TGAACTCCTGACCTC-6.22
Number of super-enhancer constituents: 7             
IDCoordinateTissue/cell
SE_10187chr8:28185946-28187090CD19_Primary
SE_10881chr8:28185524-28187600CD20
SE_58992chr8:28165452-28207351Ly3
SE_59946chr8:28164768-28207284Ly4
SE_61002chr8:28174118-28277761HBL1
SE_63042chr8:28186067-28207603Tonsil
SE_65386chr8:28186232-28187391Pancreatic_islets
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 4             
ChromosomeStartEnd
chr82818598528186042
chr82818616328186419
chr82818610128186200
chr82818620028186275
Number: 1             
IDChromosomeStartEnd
GH08I028328chr82818552528187600
Enhancer Sequence
GCCAGGCTGG TCTTGAACTC CTGACCTCTA GTGATCCACC TGCCCTGGCC TCCCAAAGTT 60
CTGGGATTAC AGGCATGAGC CACTGTGCCT GGCCCAAAGA TCCCATCTCT TAATATCATC 120
ACGTTGGAGG TTAGGATTTC AACATAGGAA TTTTAGGGAG ACAGAGATAG ACCATAGCAC 180
TAGCTCACAT CTAACAGGGA TAAGAGGCAA GTACCTGGAA GAGAGAATTC GGGGTATGGG 240
GGGTTGGGGG CATTCCTGGC TGCAGCAGGG AAGGCCAGGA GGATGAAAGG AAGCATTTGA 300
GTCATTAATA AATGTCATAT TTTACTCATC TTACTTTTGC ACAGCACTTT GCAAAACTCC 360
CCTTACAGAT CTCATTTCAT CTTCACAATA GGCCTGTGAT AAGGCAGGTG CCACTGTTCC 420
CCTTTTATGG GCTATGAAAA CTGAGGCTCA AAGTGGTTGA TTTAATGTCA CATGCTGGTA 480
AACTGCAAAG CGATGCCTTT AGCTCCCAAG AAAGCTATCT CTGCCACCAC ACAGCTGCTC 540
CCAAAAGTGC CTATGAGGTG TCGAGGCCAG CCAGGTGGCA GGAATCACAG GGGTGTCCTG 600
CCACCCAGGA CTAACCCAGG AACCCAGACA CACTAACAAG CCTCTACATG AACACTGAGC 660
CTAGGTGATA GGCAGGGTCG CCTATGGCCT TGACAATTTA CACCCCTGCA AAGTGAATCA 720
CAGGCCCCTA GTGCCATCCT GCCAGAGACA GCAGAGAAGT GTCTTTCCTG CATTCTCTGG 780
GTTAGGTCTC TGGCCCTGAG CAGCCCTCCG AGAATGGCTG TACTCATTGC CATGCTTCCT 840
GTATGTTCCA 850